Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

[1]  C. Szab,et al.  Poly(ADP-ribose) polymerase activation and the pathogenesis of circulatory shock , 2000 .

[2]  Zhao-Qi Wang,et al.  Characterization of sPARP-1 , 2000, The Journal of Biological Chemistry.

[3]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[4]  K Miyamoto,et al.  Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. , 2000, Investigative ophthalmology & visual science.

[5]  Ç. Karasu.  Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: role of reactive oxygen species. , 2000, European journal of pharmacology.

[6]  C. Ong,et al.  Detection of oxidative DNA damage in human sperm and its association with sperm function and male infertility. , 2000, Free radical biology & medicine.

[7]  M. O’connor,et al.  Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. , 1999, Molecular pharmacology.

[8]  Xueliang Du,et al.  Generation of reactive oxygen intermediates, activation of NF-κB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? , 1999 .

[9]  J. Tooke,et al.  Vascular function in Type 2 diabetes mellitus and pre‐diabetes: the case for intrinsic endotheliopathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[10]  T. Wascher,et al.  Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction? , 1999, Diabetes research and clinical practice.

[11]  R. Andriantsitohaina,et al.  Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice , 1999, The EMBO journal.

[12]  Z. Naito,et al.  Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advanced glycation end products and NF-kappa B in aorta of streptozotocin treated Mongolian gerbils. , 1999, Nihon Ika Daigaku zasshi.

[13]  K. Kamata,et al.  Effect of insulin treatment on smooth muscle contractility and endothelium‐dependent relaxation in rat aortae from established STZ‐induced diabetes , 1999, British journal of pharmacology.

[14]  M. Laakso,et al.  Reducing the burden of diabetes: managing cardiovascular disease † , 1999, Diabetes/metabolism research and reviews.

[15]  S. Snyder,et al.  Poly (ADP-ribose) polymerase, nitric oxide and cell death. , 1999, Trends in pharmacological sciences.

[16]  S. Snyder,et al.  Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Kolb,et al.  Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin , 1999, Nature Medicine.

[18]  T. Lange,et al.  Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. , 1998, Science.

[19]  B. Zingarelli,et al.  Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. , 1998, Circulation research.

[20]  H. Wong,et al.  Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  G. Remuzzi,et al.  Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. , 1998, The Journal of clinical investigation.

[22]  L. Rodríguez-Mañas,et al.  Endothelial dysfunction and metabolic control in streptozotocin‐induced diabetic rats , 1998, British journal of pharmacology.

[23]  S. Cuzzocrea,et al.  Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Barry Halliwell,et al.  Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils , 1998, Nature.

[25]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[26]  Riaz-ul-Haq,et al.  Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. , 1997, Journal of cardiovascular pharmacology.

[27]  S. Cuzzocrea,et al.  Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. , 1997, The Journal of clinical investigation.

[28]  B. Halliwell.  What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? , 1997, FEBS letters.

[29]  T. Lüscher,et al.  High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. , 1997, Circulation.

[30]  C. Rosenfeld,et al.  Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. , 1997, The American journal of physiology.

[31]  G. Pieper,et al.  Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. , 1997, Cardiovascular research.

[32]  J. Coyle,et al.  DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  M. O’connor,et al.  DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Pieper,et al.  Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. , 1996, Life sciences.

[35]  G. Pieper,et al.  Syngeneic Pancreatic Islet Transplantation Reverses Endothelial Dysfunction in Experimental Diabetes , 1995, Diabetes.

[36]  F. Luscinskas,et al.  Activation‐Dependent Isolation and Culture of Murine Pulmonary Microvascular Endothelium , 1995, Microcirculation.

[37]  J. Adams,et al.  High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions. , 1995, Analytical biochemistry.

[38]  E. Wagner,et al.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. , 1995, Genes & development.

[39]  J S Beckman,et al.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. , 1992, Archives of biochemistry and biophysics.

[40]  K. Ueda,et al.  Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. , 1992, The Journal of biological chemistry.

[41]  B. Brenner,et al.  Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha. , 1991, The American journal of physiology.

[42]  R. Furchgott.  The 1989 Ulf von Euler lecture. Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. , 1990, Acta physiologica Scandinavica.

[43]  W. Earnshaw,et al.  Detection of DNA cleavage in apoptotic cells. , 2000, Methods in enzymology.

[44]  J. Zhang.  Use of biotinylated NAD to label and purify ADP-ribosylated proteins. , 1997, Methods in enzymology.